Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MRKR

Marker Therapeutics Inc

Jun 11 • 04:00PM ET

1.37

-0.06 -4.20 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: ALLR BCTX CLRB JSPR LGVN NXTC PLUR PTN TPST VTGN

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.67	Insider Own	19.03%	Shs Outstand	16.67M	Perf Week	-6.80%
Market Cap	22.84M	Forward P/E	-	EPS next Y	-1.01	Insider Trans	0.00%	Shs Float	13.50M	Perf Month	-4.86%
Enterprise Value	7.20M	PEG	-	EPS next Q	-0.22	Inst Own	10.34%	Short Float	1.51%	Perf Quarter	1.48%
Income	-10.90M	P/S	7.14	EPS this Y	-21.94%	Inst Trans	-1.89%	Short Ratio	2.02	Perf Half Y	-8.05%
Sales	3.20M	P/B	1.66	EPS next Y	-5.19%	ROA	-63.30%	Short Interest	0.20M	Perf YTD	-8.05%
Book/sh	0.83	P/C	1.46	EPS next 5Y	-	ROE	-77.04%	52W High	4.07 -66.34%	Perf Year	-26.74%
Cash/sh	0.94	P/FCF	-	EPS past 3/5Y	39.48% 33.49%	ROIC	-78.98%	52W Low	0.81 69.16%	Perf 3Y	-45.42%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.31% 50.02%	Gross Margin	-	Volatility	4.95% 4.32%	Perf 5Y	-95.91%
Dividend TTM	-	EV/Sales	2.25	EPS Y/Y TTM	49.21%	Oper. Margin	-386.37%	ATR (14)	0.07	Perf 10Y	-98.04%
Dividend Ex-Date	-	Quick Ratio	4.79	Sales Y/Y TTM	-43.86%	Profit Margin	-340.78%	RSI (14)	42.54	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.79	EPS Q/Q	58.88%	SMA20	-4.96%	Beta	1.45	Target Price	7.87
Payout	-	Debt/Eq	0.00	Sales Q/Q	-100.00%	SMA50	-7.44%	Rel Volume	1.54	Prev Close	1.43
Employees	5	LT Debt/Eq	0.00	Earnings	May 20	SMA200	2.92%	Avg Volume	101.43K	Price	1.37
IPO	Jan 05, 1998	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% 0.00%	Trades		Volume	156,253	Change	-4.20%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)